Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M64.4Revenue (TTM) $M2.6Net Margin (%)-1,503.3Altman Z-Score-25.1
Enterprise Value $M62.0EPS (TTM) $-2.9Operating Margin %-1,527.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-1,503.3Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-31.8Quick Ratio3.3Cash flow > EarningsY
Price/Sales22.75-y EBITDA Growth Rate %-6.9Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-101.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-227.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2016-06-30 Buy $2.7 - $3.6
($3.17)
$ 4.4440%New holding250,000
SNSSFirst Eagle Investment 2015-06-30 Sold Out $12.42 - $18.06
($15.18)
$ 4.44-71%Sold Out0
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$12.6 - $16.98
($14.41)
$ 4.44-69%Reduce -58.43%97,996
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$6.3 - $39.84
($12.45)
$ 4.44-64%New holding235,713
SNSSFirst Eagle Investment 2014-09-30 Sold Out -0.0032%$33.32 - $49.38
($41.36)
$ 4.44-89%Sold Out0
SNSSFirst Eagle Investment 2014-06-30 Reduce$28.02 - $42.66
($33.25)
$ 4.44-87%Reduce -8.91%33,333
SNSSFirst Eagle Investment 2014-03-31 Reduce$24.96 - $43.8
($33.22)
$ 4.44-87%Reduce -8.50%36,593
SNSSFirst Eagle Investment 2013-12-31 Add$27.54 - $31.62
($29.53)
$ 4.44-85%Add 19.98%39,993
SNSSFirst Eagle Investment 2013-09-30 Buy $27.3 - $36.3
($30.53)
$ 4.44-85%New holding33,333
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.0052%$24 - $38.94
($31.34)
$ 4.44-86%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$15.84 - $34.56
($21.43)
$ 4.44-79%Reduce -30.24%58,333
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$15.12 - $18.66
($16.62)
$ 4.44-73%New holding83,621
SNSSFirst Eagle Investment 2012-03-31 Sold Out -0.0026%$7.32 - $17.22
($10.84)
$ 4.44-59%Sold Out0
SNSSFirst Eagle Investment 2011-12-31 Buy $6.48 - $8.7
($7.63)
$ 4.44-42%New holding83,621
SNSSFirst Eagle Investment 2009-12-31 Sold Out $10.8 - $75.24
($22.53)
$ 4.44-80%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$5.94 - $20.7
($11.71)
$ 4.44-62%Reduce -90.60%2,778
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Parker Geoffrey M.Director 2016-05-26Buy1,583$2.8257.45view
Parker Geoffrey M.Director 2016-05-25Buy8,751$2.8257.45view
Misfeldt DaytonDirector 2015-12-21Buy291,667$5.04-11.9view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy4,167$6.06-26.73view
Ketchum Steven BDirector 2015-07-24Sell1,060$20.76-78.61view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell1,060$20.76-78.61view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell2,119$20.76-78.61view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell105,951$20.76-78.61view
Misfeldt DaytonDirector 2015-07-24Sell105,951$20.76-78.61view
BARRIS PETER J10% Owner 2014-08-29Sell44,450$47.82-90.72view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Jul 28 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 12 2016
Sunesis Pharmaceuticals, Inc. Preliminary Results From the Oral Non-Covalent BTK-inhibitor SNS-062... Sep 12 2016
Sunesis Presents Dose Escalation Results from the Phase 1A Healthy Volunteer Study Evaluating Oral... Sep 12 2016
Sunesis Presents Dose Escalation Results from the Phase 1A Healthy Volunteer Study Evaluating Oral... Sep 12 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : September 9, 2016 Sep 09 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Sep 07 2016
Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split Sep 07 2016
Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split Sep 07 2016
Sunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results from the Phase 1A... Sep 01 2016
Sunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results from the Phase 1A... Sep 01 2016
Sunesis to Present at Upcoming Investor Conferences Aug 31 2016
Sunesis to Present at Upcoming Investor Conferences Aug 31 2016
Sunesis Announces Publication in "Drugs" Detailing Molecular and Pharmacologic Properties of... Aug 25 2016
Sunesis Announces Publication in "Drugs" Detailing Molecular and Pharmacologic Properties of... Aug 25 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 18, 2016 Aug 18 2016
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 23.1% Aug 18 2016
SUNESIS PHARMACEUTICALS INC Financials Aug 05 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 4, 2016 Aug 04 2016
Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 Aug 03 2016
Edited Transcript of SNSS earnings conference call or presentation 29-Jul-16 3:00pm GMT Aug 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)